ANI Pharmaceuticals to Participate at Leerink Partners Therapeutics Forum: I&I and Metabolism on July 8th
ANI Pharmaceuticals (NASDAQ:ANIP) announced its participation in the upcoming Leerink Partners Therapeutics Forum, focusing on I&I and Metabolism. The company's President and CEO, Nikhil Lalwani, will be conducting one-on-one meetings with investors during the event, which takes place on July 8, 2025, in Boston, MA.
ANI Pharmaceuticals (NASDAQ:ANIP) ha annunciato la sua partecipazione al prossimo Leerink Partners Therapeutics Forum, incentrato su I&I e Metabolismo. Il Presidente e CEO dell'azienda, Nikhil Lalwani, terrà incontri individuali con gli investitori durante l'evento, che si svolgerà il 8 luglio 2025 a Boston, MA.
ANI Pharmaceuticals (NASDAQ:ANIP) anunció su participación en el próximo Leerink Partners Therapeutics Forum, enfocado en I&I y Metabolismo. El Presidente y CEO de la compañía, Nikhil Lalwani, realizará reuniones individuales con inversores durante el evento, que tendrá lugar el 8 de julio de 2025 en Boston, MA.
ANI Pharmaceuticals (NASDAQ:ANIP)� I&I � 대사에 중점� � 다갶오� Leerink Partners Therapeutics Forum� 참여한다� 발표했습니다. 회사� 사장 � CEO� Nikhil Lalwani갶 2025� 7� 8� 보스�, MA에서 열리� 행사 기간 동안 투자자들� 일대� 미팅� 진행� 예정입니�.
ANI Pharmaceuticals (NASDAQ:ANIP) a annoncé sa participation au prochain Leerink Partners Therapeutics Forum, axé sur l'I&I et le métabolisme. Le président et CEO de la société, Nikhil Lalwani, tiendra des réunions individuelles avec des investisseurs lors de l'événement qui se déroulera le 8 juillet 2025 à Boston, MA.
ANI Pharmaceuticals (NASDAQ:ANIP) gab seine Teilnahme am bevorstehenden Leerink Partners Therapeutics Forum bekannt, das sich auf I&I und Stoffwechsel konzentriert. Der Präsident und CEO des Unternehmens, Nikhil Lalwani, wird während der Veranstaltung am 8. Juli 2025 in Boston, MA, Einzelgespräche mit Investoren führen.
- None.
- None.
PRINCETON, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI� or the “Company�) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, will host 1x1 meetings at the Leerink Partners Therapeutics Forum: I&I and Metabolism on Tuesday, July 8, 2025, in Boston, MA.
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit .
Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E:
Source: ANI Pharmaceuticals, Inc.
